---
schema_version: "secwatch.filing_event.v1"
accession: "0001754195-26-000030"
form_type: "8-K"
ticker: "TCNNF"
cik: "0001754195"
company_name: "Trulieve Cannabis Corp."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:55:47.090503+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Trulieve Q1 2026: Revenue $287M, Net Income $2M, Adjusted EBITDA $100M, Gross Margin 59%

## Summary
- Q1 revenue $287M; gross margin 59% ($170M gross profit); 92% of revenue from retail sales.
- Positive GAAP net income $2M; adjusted net income $20M; adjusted EBITDA $100M (35% of revenue).
- Cash from operations $56M, free cash flow $42M; cash at quarter end $353M.
- Closed $60M private placement of senior secured notes due 2030.
- Opened three new Florida dispensaries; rewards program reached 1M members; DEA registration enabled by Schedule III rescheduling.

## SEC filing metadata
- accession: 0001754195-26-000030
- form_type: 8-K
- ticker: TCNNF
- cik: 0001754195
- company_name: Trulieve Cannabis Corp.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1754195/000175419526000030/0001754195-26-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1754195/000175419526000030/tcnnf-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001754195-26-000030
- JSON: https://secwatch.observer/filing/0001754195-26-000030.json
- Plain text: https://secwatch.observer/filing/0001754195-26-000030.txt

## Source-grounded claims
- claim_id: d7c524092a67745920b8b4243d07aea253e0ee23
  claim: Trulieve Cannabis Corp. reported first quarter ended March 31, 2026 results: revenue $287 million, net income $2 million.
  evidence_excerpt: as Exhibit 99.1. --- EX-99.1 (EX-99.1) --- Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation • First quarter revenue of $287 million, with 59% gross margin • Positive net income of $2 million and Adjusted EBITDA of $100 million* • Rescheduling of medical marijuana to Schedule III enabled applications for DEA
  evidence_url: https://www.sec.gov/Archives/edgar/data/1754195/000175419526000030/0001754195-26-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.